Remap Consulting joined over 1,200 other delegates from pharma, biotech and Payers/HTA’s, in attending the largest and most established orphan drugs and rare disease meeting of its kind across the globe, in Barcelona, Spain from 30th October – 2nd November 2023.
Our summaries provide the key discussion points and takeaways from the keynotes and panel sessions in the Access & Pricing and Real World Evidence tracks.
Have you read our research for ISPOR Europe 2023? We’ll be exhibiting at the conference and presenting our research in Copenhagen this November. Check out the details here.